Breaking News

Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy

  

 

The Readout LOUD

When is data “practice-changing”? How many Covid-19 vaccines do we need? And what does it mean when the FDA asks for more time?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. With the world’s largest cancer conference just concluded, we explain the most important data presented at the meeting, including a blockbuster clinical trial that promises to change the treatment of advanced breast cancer. We also discuss an FDA controversy in the making, a pair of new Covid-19 vaccines, and the frustrating process of finding new treatments for depression.

Listen Now

You can find us on:








 
For older episodes, click here.
 

Friday, June 10, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments